Michael Lawrence-Brown, MD

Commentary

2002 IAGS Proceedings: Intracranial Interventions (Part I of II)

08/01/2008

Douglas M. Cavaye , MD;

James P. Zidar , MD;

Max Amor , MD;

Michael Lawrence-Brown , MD;

John Anderson , DPM, FACFAS, MD;

John Anderson: In the U.S. and in Australia, stroke is the third leading cause of death and the leading cause of disability. Yet despite this, there is an air of therapeutic nihilism about stroke. Patients who present to the emergency room...

John Anderson: In the U.S. and...

08/01/2008

Journal of Invasive Cardiology

Commentary

2002 IAGS Proceedings: Intracranial Intervention (Part II of II)

08/01/2008

Douglas M. Cavaye , MD;

James P. Zidar , MD;

Max Amor , MD;

Michael Lawrence-Brown , MD;

John Anderson , DPM, FACFAS, MD;

Richard Myler: I have always believed that you don’t read history, you repeat it. You may never have heard about Richard Schneider who was the chief of Werner Forsmann in Germany. In 1929, a 24-year-old man who worked with Schneider had the...

Richard Myler: I have always...

08/01/2008

Journal of Invasive Cardiology

IAGS (International Andreas Gruentzig Society) Proceedings

Percutaneous Abdominal Aortic Disease Management: Long-Term Results (IAGS 2004)

08/01/2008

Michael L. Marin , MD;

Eberhard Zeitler , MD;

Klemens Barth , MD;

Michael Lawrence-Brown , MD;

Ernst Schneider , MD;

Wolfgang Ritter , MD;

Andrew Cragg , MD;

Douglas M. Cavaye , MD;

Wolfgang Ritter: We know that all devices have problems; for example, the VanGuard or the AneuRx® (Medtonic, Inc., Sunnyvale, California) can incur some disintegration 4 to 5 years postimplantation. With the Zenith device, the problem of late...

Wolfgang Ritter: We know that...

08/01/2008

Journal of Invasive Cardiology